Article info

Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring

Authors

  1. Correspondence to Hieronymus T W Smeele, Erasmus MC, Rotterdam 3015 GD, The Netherlands; h.smeele{at}erasmusmc.nl
View Full Text

Citation

Smeele HTW, Röder E, Mulders AGMGJ, et al
Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring

Publication history

  • Received April 20, 2022
  • Accepted June 14, 2022
  • First published July 11, 2022.
Online issue publication 
September 12, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.